Drug and Medication Analysis & Statistics, February 2015 (p5)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

121-150 of about 7 300 reports

Purchase Reports From Reputable Market Research Publishers

Proteinuria Global Clinical Trials Review, H1, 2015

Proteinuria Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Proteinuria Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Proteinuria Global Clinical Trials Review, H1, 2015" provides data on the Proteinuria clinical trial scenario. ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World
Renal Failure Global Clinical Trials Review, H1, 2015

Renal Failure Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Renal Failure Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H1, 2015" provides data on the Renal Failure clinical trial ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Renal Stones/Calculi Global Clinical Trials Review, H1, 2015

Renal Stones/Calculi Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Renal Stones/Calculi Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H1, 2015" provides data on the Renal Stones/Calculi ...

  • Industries : Drug Discovery and Development
  • Countries : World
Generic Drugs Market in Japan 2015-2019

Generic Drugs Market in Japan 2015-2019

  • $ 2 500
  • Industry report
  • February 2015
  • by Infiniti Research Limited

About Generic Drugs A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded ...

  • Industries : Drug and Medication
  • Countries : Japan
Type 2 Diabetes - Pipeline Review, H1 2015

Type 2 Diabetes - Pipeline Review, H1 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Markets Direct

Type 2 Diabetes - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Athlete%s Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015

Athlete%s Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Athlete's Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Athlete's Foot (Tinea Pedis) Global Clinical Trials Review, H1, 2015" provides data on ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy
  • Countries : World
Analyzing the Global Pharmaceutical Industry 2015

Analyzing the Global Pharmaceutical Industry 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Aruvian's R'search

The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased revenues ...

  • Industries : Pharmaceutical
  • Countries : World, Europe, Asia
Cystinosis Global Clinical Trials Review, H1, 2015

Cystinosis Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Data

Cystinosis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H1, 2015" provides data on the Cystinosis clinical trial scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Glomerulonephritis Global Clinical Trials Review, H1, 2015

Glomerulonephritis Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Data

Glomerulonephritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Glomerulonephritis Global Clinical Trials Review, H1, 2015" provides data on the Glomerulonephritis ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Microalbuminuria Global Clinical Trials Review, H1, 2015

Microalbuminuria Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Data

Microalbuminuria Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Microalbuminuria Global Clinical Trials Review, H1, 2015" provides data on the Microalbuminuria clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015

Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Data

Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015" provides data on the Spinocerebella ...

  • Industries : Drug Discovery and Development
  • Countries : World
Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015

Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Data

Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015

Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Data

Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015

Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Data

Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
World: Ginger - Market Report. Analysis And Forecast To 2020

World: Ginger - Market Report. Analysis And Forecast To 2020

  • $ 2 886
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Global Market of Ginger. It presents the latest data of the market value, consumption, domestic production, exports and imports, price dynamics and food ...

  • Industries : Drug and Medication
World: Castor Oil Seed - Market Report. Analysis And Forecast To 2020

World: Castor Oil Seed - Market Report. Analysis And Forecast To 2020

  • $ 2 886
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Global Market of Castor oil seed. It presents the latest data of the market value, consumption, domestic production, exports and imports, price dynamics ...

  • Industries : Drug and Medication
Consumer Health in Serbia

Consumer Health in Serbia

  • $ 2 394
  • Industry report
  • April 2015
  • by Euromonitor International

The overall consumer health growth was moderately strong in current value terms. Although it was lower than the entire review period’s CAGR, it still performed well in 2014. This is largely because many ...

  • Industries : Drug and Medication
  • Countries : Serbia
Consumer Health in Dominican Republic

Consumer Health in Dominican Republic

  • $ 2 394
  • Industry report
  • April 2015
  • by Euromonitor International

Changing consumer lifestyles had the greatest impact on the growth and characteristics of consumer health in the Dominican Republic on numerous fronts. The continued trend toward urbanisation, spurred ...

  • Industries : Drug and Medication
  • Countries : Dominican Republic
Consumer Health in Ecuador

Consumer Health in Ecuador

  • $ 2 394
  • Industry report
  • April 2015
  • by Euromonitor International

Overall growth in consumer health in Ecuador in 2014 was slower than over the review period. The various industry changes due to government regulations – import barriers and price controls – took most ...

  • Industries : Drug and Medication
  • Countries : Ecuador
Consumer Health in the Netherlands

Consumer Health in the Netherlands

  • $ 2 394
  • Industry report
  • April 2015
  • by Euromonitor International

In 2014, consumer health in the Netherlands posted slightly stronger current value growth than in 2013 but a weaker performance than the review period CAGR. Uncertain economic conditions contributed to ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Consumer Health in Sweden

Consumer Health in Sweden

  • $ 2 394
  • Industry report
  • April 2015
  • by Euromonitor International

In 2014, consumer health saw healthy growth in retail value sales terms. This growth, however, was not evenly distributed across the consumer health categories. There were deviations from this relatively ...

  • Industries : Drug and Medication
  • Countries : Sweden
Consumer Health in Costa Rica

Consumer Health in Costa Rica

  • $ 2 394
  • Industry report
  • April 2015
  • by Euromonitor International

Despite the ongoing economic uncertainty in Costa Rica in 2014, consumer health showed good growth. The rising awareness of self-care and healthy lifestyles, in combination with sports participation and ...

  • Industries : Drug and Medication
  • Countries : Costa Rica
Consumer Health in the Czech Republic

Consumer Health in the Czech Republic

  • $ 2 394
  • Industry report
  • April 2015
  • by Euromonitor International

Performance of retail value sales of consumer health was better in 2014 compared to that of 2013 and was also better than that seen over the review period (value CAGR). Sales were driven by rising demand ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Consumer Health in Slovenia

Consumer Health in Slovenia

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

Deepening economic problems in the country have negatively affected the entire consumer health industry. Consumers became extremely price sensitive and excluded all unnecessary products from their shopping ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Consumer Health in Norway

Consumer Health in Norway

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

Consumer health in Norway continues to develop steadily, displaying marginally stronger growth in 2014 than during the review period. Economic fluctuations and uncertainty did not affect consumer health ...

  • Industries : Drug and Medication
  • Countries : Norway
Consumer Health in Estonia

Consumer Health in Estonia

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

As Estonian consumers were becoming increasingly confident in economic terms with the country gradually fully recovering from the recession, value sales of consumer health products were seeing positive ...

  • Industries : Drug and Medication
  • Countries : Estonia
Consumer Health in Tunisia

Consumer Health in Tunisia

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

Due to the ongoing rapid evolution of the Tunisian pharmaceutical industry, many of the country’s leading manufacturers of consumer health products believe that it is possible to generate further strong ...

  • Industries : Drug and Medication
  • Countries : Tunisia
Consumer Health in Latvia

Consumer Health in Latvia

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

In 2014, consumer health saw strong growth in Latvia due to increasing consumer purchasing power and higher disposable incomes. This changed consumer habits, as many preferred premium products. Furthermore, ...

  • Industries : Drug and Medication
  • Countries : Latvia
Consumer Health in Guatemala

Consumer Health in Guatemala

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

In 2014 consumer health saw healthy retail value growth, growing slightly faster than the growth recorded over 2009-2014 review period. Marketing campaigns, educational campaigns, new product developments ...

  • Industries : Drug and Medication
  • Countries : Guatemala
Consumer Health in Venezuela

Consumer Health in Venezuela

  • $ 2 394
  • Industry report
  • March 2015
  • by Euromonitor International

Consumer health grew in both volume and current value terms despite the general context of the economic crisis. The industry made efforts to maintain product availability. The Venezuelan government provided ...

  • Industries : Drug and Medication
  • Countries : Venezuela
About 22 000 reports

Download Unlimited Documents from Trusted Public Sources

Cancer Drug Market in Mexico

  • April 2015
    2 pages
  • Cancer Drug  

    Public Health I...  

    Pharmaceutical  

  • Mexico  

    Brazil  

    North America  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.